Overview

Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.

Status:
Completed
Trial end date:
2018-05-25
Target enrollment:
Participant gender:
Summary
Bioequivalence Study of Empagliflozin Tablets and Jardiance® Under Fasting and Fed Conditions in Chinese Healthy Volunteers.
Phase:
N/A
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Treatments:
Empagliflozin